Your trusted destination for CME, CPD & Medical Education across the Middle East.
Biomedical Sciences Program, Helmy Institute for Medical Sciences, Zewail City of Science and Technology
Dr. Ayman El-Shibiny is an internationally renowned microbiologist, academic leader, and leading authority in phage therapy and food biosecurity across the Middle East and North Africa. He earned his PhD in Microbiology from the University of Nottingham in the United Kingdom, focusing his doctoral research on food-borne pathogens, microbial ecology, and bacteriophage intervention strategies against zoonotic bacterial contamination in agriculture and food processing systems.
Following his PhD, Dr. El-Shibiny conducted extensive postdoctoral research across distinguished international institutions, including the University of Nottingham (UK), Cardiff University (UK), and The Evergreen State College (USA). During these appointments, he established robust research collaborations with international laboratories across Europe, North America, and the MENA region, pioneering the application of bacteriophages as targeted, natural biocontrol agents to complement or replace conventional antibiotics in veterinary medicine, food production, and clinical healthcare settings.
Currently, Dr. El-Shibiny serves as Director of the Center for Microbiology and Phage Therapy (CMP) and Director of the Center of Scientific Excellence for Food Research and Analysis (cSEFRA) at Zewail City of Science and Technology in Egypt. He is also a Professor in the Biomedical Sciences Program at the Helmy Institute for Medical Sciences and the Founding Director of the Food Safety and Quality Professional Diploma. In his administrative and scientific roles, he leads multi-disciplinary teams dedicated to translational microbiology, phage formulation stability, pathogen genomics,and food safety standards.
Dr. El-Shibiny’s primary research focuses on bacteriophage therapy as a cutting-edge precision tool to combat multi-drug resistant (MDR) pathogens, including Campylobacter jejuni, Escherichia coli O157:H7, Salmonella enterica,Staphylococcus aureus, and Pseudomonas aeruginosa. His laboratory isolates, characterizes, and formulates target-specific lytic phages for application in food supply security, veterinary infection control, and human therapeutic models.A prolific scholar, Dr. El-Shibiny has co-authored numerous peer-reviewed scientific publications, book chapters, and research monographs in top-tier journals such as Applied and Environmental Microbiology, Veterinary Microbiology, and International Journal of Food Microbiology.
At international scientific symposia and regional biotechnology forums, Dr. El-Shibiny is a prominent keynote speaker and program director. Translating phage biology into scalable clinical and agricultural solutions, he guides medical professionals, biotechs, and public health officials on harnessing bacteriophages to address the growing global crisis of antimicrobial resistance (AMR).

Sidra Medicine
Sidra Medicine